Postdoctoral Scholar Positions - Adams Lab

$60,000 – 66,909
Will remain open until filled

The UC Irvine Department of Chemical and Biomolecular Engineering is currently accepting applications for a postdoctoral scholar position (Level 0 to Level 3) in the laboratory of Tayloria N.G. Adams, Ph.D. The applicant will work at the interface of stem cell biology and bioengineering, carrying out essential research and administrative duties.

Stem cells are of interest in cell therapy research because they differentiate into multiple distinct cell types, have positive immunomodulatory effects, and secrete bioactive molecules. Due to stem cells’ unique properties, biomanufacturing to generate populations of cells that can be further studied or used as therapeutics has emerged as a vital area of research. A challenge to biomanufacturing stem cells is the heterogeneity of stem cell cultures, which contain stem cells, partially differentiated progenitor cells and fully differentiated cells. An impediment to effectively harnessing stem cell therapeutic potential is the inability to detect or select specific cell subpopulations due to an insufficient number of biomarkers. The major goals of this postdoctoral scholar position are to sort progenitor populations of stem cells using electrode-based microfluidic platforms and study their biological differences with an emphasis on stem cell therapeutics.

The Samueli School of Engineering and Sue and Bill Gross Stem Cell Research Center offers an exceptional interdisciplinary environment for biomedical research and professional development, with connections to the School of Medicine, School of Biological Sciences and School of Physical Sciences. This postdoctoral scholar position will enable an early career scholar the opportunity to pursue timely and impactful research, innovate microfluidic technology and build professional networks within different scientific communities. Research efforts include the integration of stem cell biology (i.e., differentiation, immunomodulatory signaling, gene regulation and expression), microfluidic cell sorting and biomarker development in order to improve understanding and the manipulation of stem cell heterogeneity.

The position requires a doctorate in chemical engineering, biomedical engineering, bioengineering or a closely related field with expertise in cell separations. Areas of specific interest include microfluidic device fabrication, electrode-based cell sorting, label-free biomarkers, dielectrophoresis, regenerative medicine, tissue engineering and epigenetics. The candidate should have hands-on learning experience including the ability to conduct literature reviews, design experiments, collect and analyze large data sets, and interpret results. Initial appointment will be for a 24-month period, renewable subject to performance and funding availability.

Applicants should submit a cover letter, curriculum vitae, publications and contact information for three references. Apply by submitting your application to our online RECRUIT system at:

The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.

As a condition of employment, you will be required to comply with the University of California Policy on Vaccination Programs – With Updated Interim Amendments. All Covered Individuals under the policy must provide proof of receiving the COVID-19 Vaccine Primary Series or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, Religious Objection, and/or Deferral based on pregnancy or recent COVID-19 diagnosis and/or treatment) no later than the applicable deadline. All Covered Individuals must also provide proof of receiving the most recent CDC-recommended COVID-19 booster or properly decline such booster no later than the applicable deadline. New University of California employees should refer to Exhibit 2, Section II.C. of the SARS-CoV-2 (COVID-19) Vaccination Program Attachment for applicable deadlines. All Covered Individuals must also provide proof of being up-to-date on seasonal influenza vaccination or properly decline such vaccination no later than the applicable deadline. Please refer to the Seasonal Influenza Vaccination Program Attachment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements.